NCT00448552View on ClinicalTrials.gov

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

June 30, 2008

Conditions
Head and Neck Cancer
Interventions
DRUG

capecitabine

DRUG

oxaliplatin

Trial Locations (1)

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT00448552 - Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer | Biotech Hunter | Biotech Hunter